Challenges in the Management of Breast Cancer in Low- and Middle-Income Countries

• Kelsey JL , Horn-RossPL. Breast cancer: magnitude of the problem and descriptive epidemiology.Epidemiol. Rev.15, 7–16 (1993).
   PubMed Web of Science ®Google Scholar
• Yost K , PerkinsC, CohenRet al. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control 12, 703–711 (2001).
   PubMed Web of Science ®Google Scholar
• Coleman MP , QuaresmaM, BerrinoFet al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol. 9, 730–756 (2008).
   PubMed Web of Science ®Google Scholar
• Parkin DM , FernandezLM. Use of statistics to assess the global burden of breast cancer.Breast J.12(Suppl. 1), S70–S80 (2006).
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R , SwaminathanR, JayantK, BrennerH. An overview of cancer survival in Africa, Asia, the Caribbean and Central America: the case for investment in cancer health services, (SurvCan). IARC Scientific Publications volume 162, International Agency for Research on Cancer (2011).
   Google Scholar
• Parkin DM , NamboozeS, Wabwire-MangenF, WabingaHR. Changing cancer incidence in Kampala, Uganda, 1991–2006.Int. J. Cancer126, 1187–1195 (2010).
   PubMed Web of Science ®Google Scholar
• Jemal A , CenterMM, DeSantisC, WardEM. Global patterns of cancer incidence and mortality rates and trends.Cancer Epidemiol. Biomarkers Prev.19, 1893–1907 (2010).
   PubMed Web of Science ®Google Scholar
• Porter P . ‘Westernizing’ women’s risks? Breast cancer in lower-income countries. N. Engl. J. Med.358, 213–216 (2008).
   PubMed Web of Science ®Google Scholar
• Curado M , VotiL, Sortino-RachouA. Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care.Cancer Causes Control20, 751–756 (2009).
   PubMed Web of Science ®Google Scholar
• Adebamowo CA , AjayiOO. Breast cancer in Nigeria.West Afr. J. Med.19, 179–191 (2000).
   PubMedGoogle Scholar
• Kamangar F , DoresGM, AndersonWF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.J. Clin. Oncol.24, 2137–2150 (2006).
   PubMed Web of Science ®Google Scholar
• Agarwal G , RamakantP, ForgachERet al. Breast cancer care in developing countries. World J. Surg. 33, 2069–2076 (2009).
   PubMed Web of Science ®Google Scholar
• Story HL , LoveRR, SalimRet al. Improving outcomes from breast cancer in a low-income country: lessons from Bangladesh. Int. J. Breast Cancer 2012, 423562 (2012).
   PubMedGoogle Scholar
• Taib NA , YipCH, LowWY. Recognising symptoms of breast cancer as a reason for delayed presentation in Asian women – the psycho-socio-cultural model for breast symptom appraisal: opportunities for intervention.Asian Pac. J. Cancer Prev.12, 1601–1608 (2011).
   PubMedGoogle Scholar
• Pisani P , ParkinDM, NgelangelCet al. Outcome of screening by clinical examination of the breast in a trial in the Philippines. Int. J. Cancer 118, 149–154 (2006).
   PubMed Web of Science ®Google Scholar
• Thomas DB , GaoDL, RayRMet al. Randomized trial of breast self-examination in Shanghai: final results. J. Natl Cancer Inst. 94, 1445–1457 (2002).
   PubMed Web of Science ®Google Scholar
• Sankaranarayanan R , RamadasK, TharaSet al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J. Natl Cancer Inst. 103, 1476–1480 (2011).
   PubMedGoogle Scholar
• Mittra I , MishraGA, SinghSet al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int. J. Cancer 126, 976–984 (2010).
   PubMed Web of Science ®Google Scholar
• Burton RC , BellRJ, ThiagarajahG, StevensonC. Adjuvant therapy, not mammographic screening, accounts for most of the observed breast cancer specific mortality reductions in Australian women since the national screening program began in 1991.Breast Cancer Res. Treat.131, 949–955 (2012).
   PubMed Web of Science ®Google Scholar
• Ng EH , NgFC, TanPHet al. Results of intermediate measures from a population-based, randomized trial of mammographic screening prevalence and detection of breast carcinoma among Asian women: the Singapore Breast Screening Project. Cancer 82, 1521–1528 (1998).
   PubMed Web of Science ®Google Scholar
• Kesson EM , AllardiceGM, GeorgeWDet al. Effects of multidisciplinary team working on breast cancer survival: retrospective, comparative, interventional cohort study of 13 722 women. BMJ 344, e2718 (2012).
   PubMed Web of Science ®Google Scholar
• Shyyan R , MasoodS, BadweRAet al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 12(Suppl. 1), S27–S37 (2006).
   PubMed Web of Science ®Google Scholar
• Stalsberg H , AwuahB, IbarraJA, Nsiah-AsareA. Re-establishing a surgical pathology service in Kumasi, Ghana: case report and discussion of barriers and key elements of a successful collaboration between low- and high-resource countries.Cancer113, 2338–2346 (2008).
   PubMed Web of Science ®Google Scholar
• Anderson BO , CazapE, El SaghirNSet al. Optimisation of breast cancer management in low-resource and middle-resource countries: executive summary of the Breast Health Global Initiative consensus, 2010. Lancet Oncol. 12, 387–398 (2011).
   PubMed Web of Science ®Google Scholar
• Eniu A , CarlsonRW, El SaghirNSet al. Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Cancer 113, 2269–2281 (2008).
   PubMed Web of Science ®Google Scholar
• Thorat MA , RangoleA, NadkarniMSet al. Revision surgery for breast cancer: single-institution experience. Cancer 113, 2347–2352 (2008).
   PubMed Web of Science ®Google Scholar
• Salminen EK , KielK, IbbottGSet al. International Conference on Advances in Radiation Oncology (ICARO): outcomes of an IAEA meeting. Radiat. Oncol. 6, 11 (2011).
   PubMed Web of Science ®Google Scholar
• Bedard PL , Di LeoA, Piccart-GebhartMJ. Taxanes: optimizing adjuvant chemotherapy for early-stage breast cancer.Nat. Rev. Clin. Oncol.7, 22–36 (2010).
   PubMed Web of Science ®Google Scholar
• Eisen A , TrudeauM, ShelleyWet al. Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: a systematic review. Cancer Treat. Rev. 34, 157–174 (2008).
   PubMed Web of Science ®Google Scholar
• Gonzalez-Angulo AM , HortobagyiGN, EstevaFJ. Adjuvant therapy with trastuzumab for HER-2/neu-positive breast cancer.Oncologist11, 857–867 (2006).
   PubMed Web of Science ®Google Scholar
• Ghosh J , GuptaS, DesaiSet al. Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian J. Cancer 48, 391–396 (2011).
   PubMed Web of Science ®Google Scholar
• Bines J , EniuA. Effective but cost-prohibitive drugs in breast cancer treatment: a clinician’s perspective.Cancer113, 2353–2358 (2008).
   PubMed Web of Science ®Google Scholar
• Wright M , WoodJ, LynchT, ClarkD. Mapping levels of palliative care development: a global view.J. Pain Symptom Manage.35, 469–485 (2008).
   PubMed Web of Science ®Google Scholar
• Bosnjak S , MaurerMA, RyanKMet al. Improving the availability and accessibility of opioids for the treatment of pain: the International Pain Policy Fellowship. Support Care Cancer 19, 1239–1247 (2011).
   PubMed Web of Science ®Google Scholar
• Xu K , EvansDB, CarrinGet al. Protecting households from catastrophic health spending. Health Aff. (Millwood) 26, 972–983 (2007).
   PubMed Web of Science ®Google Scholar
• Yip CH , AndersonBO. The breast health global initiative: clinical practice guidelines for management of breast cancer in low- and middle-income countries.Expert Rev. Anticancer Ther.7, 1095–1104 (2007).
   PubMed Web of Science ®Google Scholar
• Anderson BO , BraunS, CarlsonRWet al. Overview of breast health care guidelines for countries with limited resources. Breast J. 9(Suppl. 2), S42–S50 (2003).
   PubMedGoogle Scholar
• Anderson BO , ShyyanR, EniuAet al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 12(Suppl. 1), S3–S15 (2006).
   PubMed Web of Science ®Google Scholar
• Anderson BO , YipCH, SmithRAet al. Guideline implementation for breast healthcare in low-income and middle-income countries: overview of the Breast Health Global Initiative Global Summit 2007. Cancer 113, 2221–2243 (2008).
   PubMed Web of Science ®Google Scholar
• Harford J , AzavedoE, FischiettoM. Guideline implementation for breast healthcare in low- and middle-income countries: breast healthcare program resource allocation.Cancer113, 2282–2296 (2008).
   PubMed Web of Science ®Google Scholar
• Penaloza B , PantojaT, BastiasGet al. Interventions to reduce emigration of health care professionals from low- and middle-income countries. Cochrane Database Syst. Rev. 9, CD007673 (2011).
   Google Scholar
• Stjernsward J . Palliative care: the public health strategy.J. Public Health Policy28, 42–55 (2007).
   PubMed Web of Science ®Google Scholar
• Errico KM , RowdenD. Experiences of breast cancer survivor-advocates and advocates in countries with limited resources: a shared journey in breast cancer advocacy.Breast J.12(Suppl. 1), S111–S116 (2006).
   PubMed Web of Science ®Google Scholar
• Bhoo-Pathy N , HartmanM, YipCHet al. Ethnic differences in survival after breast cancer in South East Asia. PLoS One 7, e30995 (2012).
   PubMed Web of Science ®Google Scholar
• Yip CH , PathyNB, UiterwaalCSet al. Factors affecting estrogen receptor status in a multiracial Asian country: an analysis of 3557 cases. Breast 20(Suppl. 2), S60–S64 (2011).
   PubMedGoogle Scholar
• Love RR . Defining a global research agenda for breast cancer.Cancer113, 2366–2371 (2008).
   PubMed Web of Science ®Google Scholar

Websites

• The World Bank Classification of Countries. http://data.worldbank.org/about/country-classifications (Assessed 12 June 2012)
   Google Scholar
• GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet] International Agency for Research on Cancer. http://globocan.iarc.fr/factsheet.asp (Accessed 12 June 2012)
   Google Scholar
• WHO Model List of Essential Medicines 17th Edition (March 2011). http://whqlibdoc.who.int/hq/2011/a95053_eng.pdf (Accessed 24 June 2012)
   Google Scholar
• Gauri V. Are Incentives Everything? Payment Mechanisms for Health Care Providers in Developing Countries. http://elibrary.worldbank.org/content/workingpaper/10.1596/1813-9450-2624 (Assessed 24 June 2012)
   Google Scholar
• The World Bank: Total Health Expenditure. http://data.worldbank.org/indicator/SH.XPD.TOTL.ZS (Assessed 24 June 2012)
   Google Scholar